Investigation on Renal Protective Effect by Luseogliflozin
Phase of Trial: Phase II
Latest Information Update: 11 Apr 2019
Price : $35 *
At a glance
- Drugs Luseogliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 09 Apr 2019 Status changed from recruiting to discontinued.
- 18 Jul 2018 Status changed from not yet recruiting to recruiting.
- 03 Apr 2018 New trial record